share_log

Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

精選醫療控股公司(紐約證券交易所代碼:SEM)在未來價值成倍增長方面還有更多工作要做
Simply Wall St ·  02/26 14:50

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that, an expanding base of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. In light of that, when we looked at Select Medical Holdings (NYSE:SEM) and its ROCE trend, we weren't exactly thrilled.

如果你正在尋找一款多功能裝袋機,有幾件事需要注意。通常,我們希望注意到增長的趨勢 返回 在資本使用率(ROCE)方面,除此之外,還在擴大 基礎 所用資本的比例。歸根結底,這表明這是一家以不斷提高的回報率對利潤進行再投資的企業。有鑑於此,當我們研究精選醫療控股公司(紐約證券交易所代碼:SEM)及其投資回報率趨勢時,我們並不十分興奮。

Understanding Return On Capital Employed (ROCE)

了解資本使用回報率 (ROCE)

For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. Analysts use this formula to calculate it for Select Medical Holdings:

對於那些不確定ROCE是什麼的人,它衡量的是公司從其業務中使用的資本中可以產生的稅前利潤金額。分析師使用以下公式來計算精選醫療控股的金額:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

已動用資本回報率 = 息稅前收益 (EBIT) ¥(總資產-流動負債)

0.086 = US$555m ÷ (US$7.7b - US$1.2b) (Based on the trailing twelve months to December 2023).

0.086 = 5.55億美元 ÷(77億美元-12億美元) (基於截至2023年12月的過去十二個月)

So, Select Medical Holdings has an ROCE of 8.6%. In absolute terms, that's a low return but it's around the Healthcare industry average of 10.0%.

因此,精選醫療控股公司的投資回報率爲8.6%。從絕對值來看,回報率很低,但約爲醫療保健行業的平均水平10.0%。

roce
NYSE:SEM Return on Capital Employed February 26th 2024
紐約證券交易所:SEM 2024年2月26日動用資本回報率

Above you can see how the current ROCE for Select Medical Holdings compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free analyst report for Select Medical Holdings .

在上面你可以看到Select Medical Holdings當前的投資回報率與其先前的資本回報率相比如何,但從過去可以看出來的只有那麼多。如果您有興趣,可以在我們爲Select Medical Holdings提供的免費分析師報告中查看分析師的預測。

What Does the ROCE Trend For Select Medical Holdings Tell Us?

精選醫療控股的投資回報率趨勢告訴我們什麼?

In terms of Select Medical Holdings' historical ROCE trend, it doesn't exactly demand attention. The company has employed 22% more capital in the last five years, and the returns on that capital have remained stable at 8.6%. This poor ROCE doesn't inspire confidence right now, and with the increase in capital employed, it's evident that the business isn't deploying the funds into high return investments.

就精選醫療控股公司的歷史投資回報率趨勢而言,這並不完全值得關注。在過去五年中,該公司僱用的資本增加了22%,該資本的回報率一直穩定在8.6%。這種糟糕的投資回報率目前並不能激發信心,隨着所用資本的增加,很明顯,該企業沒有將資金部署到高回報的投資中。

Our Take On Select Medical Holdings' ROCE

我們對精選醫療控股公司投資回報率的看法

Long story short, while Select Medical Holdings has been reinvesting its capital, the returns that it's generating haven't increased. Since the stock has gained an impressive 97% over the last five years, investors must think there's better things to come. However, unless these underlying trends turn more positive, we wouldn't get our hopes up too high.

長話短說,儘管Select Medical Holdings一直在對其資本進行再投資,但其產生的回報並沒有增加。由於該股在過去五年中上漲了令人印象深刻的97%,因此投資者必須認爲會有更好的事情發生。但是,除非這些潛在趨勢變得更加樂觀,否則我們不會抱太高的希望。

Select Medical Holdings does have some risks, we noticed 2 warning signs (and 1 which makes us a bit uncomfortable) we think you should know about.

Select Medical Holdings確實存在一些風險,我們注意到兩個警告信號(還有一個讓我們有點不舒服),我們認爲你應該知道。

If you want to search for solid companies with great earnings, check out this free list of companies with good balance sheets and impressive returns on equity.

如果你想尋找收益豐厚的穩健公司,可以免費查看這份資產負債表良好且股本回報率可觀的公司名單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論